Room G-301, Bodine Center
Philadelphia, PA 19107
(215) 955-6702
(215) 955-0412 fax
Most Recent Peer-reviewed Publications
- A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
- A phase i study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas
- Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation-A comparison with traditional techniques
- Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: A retrospective cohort study
- Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas
Medical School
Wroclaw Medical Academy, Wroclaw, Poland
Residency
Tufts-New England Medical Center, Boston (3 years)
Hospital of the University of Pennsylvania, Philadelphia, PA (1 year)
Board Certification
American Board of Radiology (Radiation Oncology), 1994
University Appointment
1995 - 2001: Assistant Professor
2001 - 2009: Associate Professor
2010 - Present: Professor
Research and Clinical Interests
Dr. Werner-Wasik is a board certified radiation oncologist, specializing in thoracic and central nervous system malignancies. She is particularly interested in the delicate balance between therapeutic intensification and toxicity management, as well as in PET-based response to radiation therapy in lung cancer. She serves as a Co-Director of the Brain Tumor Center and the Director of the Stereotactic Radiosurgery Program at the Jefferson Hospital for Neuroscience and the Residency Program Director in the Department of Radiation Oncology.
In 2009 Maria was appointed the Institutional Principal Investigator for the Radiation Therapy Oncology Group (RTOG) at Thomas Jefferson University & Hospitals and in 2011, the Vice Chair of the RTOG Publications Committee. SheI has been the principal investigator of several clinical trials which help define the standard of care for lung cancer.
Dr. Werner-Wask frequently lectures on lung cancer or brain tumors at national and international conferences such as the American Society for Therapeutic Radiation Oncology (ASTRO), the American Society for Clinical Oncology (ASCO), and the International Association for the Study of Lung Cancer (IASLC) World Conference.
She also serves as an Oral Examiner during the Radiation Oncology Specialty Board annual examination in Louisville, KY.
In the Radiation Oncology Department, Maria leads the program of Stereotactic Body Radiation Therapy (SBRT) for early stage lung cancer and lung metastases. This is an extension of our Department’s long term experience in brain stereotactic radiosurgery and radiotherapy for both benign and malignant brain tumors, as well as tumors metastatic to the spine.
Between 2009 and 2011, She was fortunate to have been awarded several "Best Doctor" titles (Philadelphia Top Doctor; America's Top Doctors for Cancer; America's Top Doctors).